Abstract:The phase evolution with temperature in the 0.98PbZrO3-0.02Pb(Ni1/3Nb2/3)O3ceramic was investigated with dielectricpermittivity and polarization measurements, hot stage transmission electron microscopy, and high temperature x-ray diffraction. Below 190 °C, the ceramic is in the antiferroelectric phase with characteristic 14{110}csuperlatticediffractions. In this stage, typical antiferroelectric 180° domains were observed. Between 190 and 220 °C, an intermediate phase, which is characterized by 12{110}c-type su… Show more
“…4(b), close examination of the hysteresis loop at 155 • C reveals that slight distortions, which are marked by two circles, occurred at ∼10 kV/cm. Similar distortions were found on the hysteresis loop in 0.98PbZrO 3 -0.02Pb(Ni 1/3 Nb 2/3 )O 3 and Pb 0.99 Nb 0.02 [Zr 0.57 Sn 0.43 ] 1−x Ti x ] 0.98 O 3 ceramics, and these have been attributed to the onset of electric field-induced AFE to FE transition [28,29]. Therefore, the 0.94PZ-0.06PMW ceramic is still in the AFE phase at this temperature and it should be noted that the distortions marked at 155 • C in Fig.…”
Section: Resultssupporting
confidence: 63%
“…It is apparent that replacement of the Zr 4+ ion by Mg 2+ /W 6+ ions decreases the driving force for the antiparallel shift of Pb 2+ ions, because they interrupt the translational symmetry. This interruption causes the appearance of an intermediate ferroelectric phase and similar behavior has been found in PZ-PNN ceramics [28].The DSC technique was used as the third tool to confirm the phase transition of PZ-PMW ceramics. Fig.…”
“…4(b), close examination of the hysteresis loop at 155 • C reveals that slight distortions, which are marked by two circles, occurred at ∼10 kV/cm. Similar distortions were found on the hysteresis loop in 0.98PbZrO 3 -0.02Pb(Ni 1/3 Nb 2/3 )O 3 and Pb 0.99 Nb 0.02 [Zr 0.57 Sn 0.43 ] 1−x Ti x ] 0.98 O 3 ceramics, and these have been attributed to the onset of electric field-induced AFE to FE transition [28,29]. Therefore, the 0.94PZ-0.06PMW ceramic is still in the AFE phase at this temperature and it should be noted that the distortions marked at 155 • C in Fig.…”
Section: Resultssupporting
confidence: 63%
“…It is apparent that replacement of the Zr 4+ ion by Mg 2+ /W 6+ ions decreases the driving force for the antiparallel shift of Pb 2+ ions, because they interrupt the translational symmetry. This interruption causes the appearance of an intermediate ferroelectric phase and similar behavior has been found in PZ-PNN ceramics [28].The DSC technique was used as the third tool to confirm the phase transition of PZ-PMW ceramics. Fig.…”
“…Superlattice reflection peaks and a splitting (200) peak were observed at roughly 43° in the compositions, 0.02 ≤ x ≤ 0.04, ¼ ( hkl ). These results indicated that the crystal structure of ceramics is orthorhombic at the compositions, 0.02 ≤ x ≤ 0.04 . The XRD pattern for the composition, x = 0.06, showed a single (200) and split (111) reflection, indicating that the crystal structure was a rhombohedral perovskite.…”
Section: Resultsmentioning
confidence: 85%
“…The compositions 0.02 ≤ x ≤ 0.06 have the same crystal structure with pure PZ ( x = 0.00), i.e., an orthorhombic unit cell at room temperature. Furthermore, the ¼ ( hkl ) superlattice reflection peaks, representing the antiparallel shifts of Pb 2+ ions in the perovskite structure, were obtained for the compositions, 0.02 ≤ x ≤ 0.06 . However, their intensity became weaker with increasing BAN content.…”
Section: Resultsmentioning
confidence: 93%
“…Therefore, not only the ionic size of substituent in the PbZrO 3 ‐based system but also the phase stability of t may be factors to consider. Furthermore, our research group studied the effect of adding hybrid‐dope such as Ni 2+ /Nb 5+ , Zn 2+ /Nb 5+ , Co 2+ /Nb 5+ , Mg 2+ /W 6+ , and Y 3+ /Nb 5+ at the Zr 4+ ‐site of the PZ structure and found that the FE and AFE phase can be stabilized by adding hybrid‐dope with an average radii ionic size that is smaller and higher than Zr 4+ ion, respectively. Therefore, this work dealt with the binary system of (1− x )PbZrO 3 − x Ba(Al 1/2 Nb 1/2 )O 3 (PZ–BAN), which replaced ions at the A‐site and B‐site by substituting with large Ba 2+ ions and hybrid‐dope Al 3+ /Nb 5+ ions, respectively.…”
Solid solution of the (1Àx)PbZrO 3 ÀxBa(Al 1/2 Nb 1/2 )O 3 system, with x = 0.02-0.30, was prepared using solid state reaction. The effect of Ba(Al 1/2 Nb 1/2 )O 3 on phase transitions and thermal and electrical properties was investigated. The stability of ferroelectric phase in pure PZ was found to improve with increasing BAN content, which corresponded to the increased tolerance factor (t) of solid solution. In comparison to other systems, results in this study indicated that the tolerance factor can predict the ferroelectric (FE)/antiferroelectric (AFE) stability of PZ-based solid solution. If the t value of solid solution is higher than pure PZ, the FE phase can be induced. On the other hand, the AFE phase is stabilized when the t value of solid solution is lower than pure PZ. D. Lupascu-contributing editor Manuscript No. 30935.
The (1 − x)Bi(Zn 1/2 Ti 1/2)O 3-xPbZrO 3 solid solution ceramics were prepared by using solid-state reaction method, and their ferroelectric properties were investigated. It was found that the perovskite structure is stable for compositions with x ≥ 0.900. Within this composition range, the crystal structure of the solid solution preserves the orthorhombic symmetry of PbZrO 3 (PZ). The Curie point of the ceramics was found to decrease with increasing Bi(Zn 1/2 Ti 1/2)O 3 (BZT) content. The intermediate ferroelectric phase of PZ was stabilized by BZT addition and exists within a much wider temperature range in the solid solution.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.